Massive Bio

Name: Massive Bio
Address: Dallas, TX, 75202, US
Telephone: +902162259478

Empowering cancer patients globally through our AI-based, clinical trial matching platform, always 100% free. Providing options & hope.

08/06/2026

Massive Bio has been named an OpenAI Select Partner within the OpenAI Partner Network.

This status builds on our continued work with OpenAI to bring GPT‑5.6 and ChatGPT Work into governed, oncology-specific AI workflows, helping healthcare and life sciences organizations move from promising pilots to measurable, production-scale impact in clinical research.

Read the full press release here: https://www.businesswire.com/news/home/20260805332425/en/Massive-Bio-Named-an-OpenAI-Select-Partner

08/04/2026

Massive Bio has made its inaugural strategic investment in another AI company: Rivvi AI, Inc., an agentic AI infrastructure company for healthcare and life sciences.

The investment connects Massive Bio's prospectively validated oncology intelligence with Rivvi's agentic AI layer for healthcare, so patients can move from identification to informed action faster and with the right human support along the way.

Our Co-Founder and CEO Selin Kurnaz, our Chief Medical AI Officer Arturo Loaiza-Bonilla, and our Co-Founder, CTO & COO Çağatay Çulcuoğlu shared their perspectives on the announcement, alongside Rivvi Co-Founder and CEO Nathan Hayman.

Read the full press release here: https://www.businesswire.com/news/home/20260804887267/en/Massive-Bio-Makes-Inaugural-Strategic-Investment-in-Rivvi-to-Build-an-End-to-End-AI-Engagement-Infrastructure-for-Healthcare

07/30/2026

We're excited to share that Massive Bio, Inc has been named an OpenAI Select Partner.

As part of the OpenAI Partner Network, we look forward to continuing our work with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively.

We're proud to be part of this next chapter. Learn more: https://openai.com/business/partners/

07/29/2026

Massive Bio and Healthcare have announced a national collaboration to transform cancer patient access, pairing Massive Bio's AI-driven clinical trial matching and patient navigation with QC Healthcare's nationwide telehealth and acute-care platforms.

The goal: give cancer patients rapid, coordinated access to care without ever stepping outside the trials that could save their lives, while keeping trial matching completely free to patients.

Read the full press release here: https://www.businesswire.com/news/home/20260729730523/en/Massive-Bio-and-QC-Healthcare-Announce-National-Collaboration-to-Transform-Cancer-Patient-Access

07/27/2026

Massive Bio and GELL, the Latin American Study Group on Lymphoproliferative Disorders, have announced a strategic partnership to advance clinical research, physician education, and AI adoption across Latin America and the United States.

The collaboration brings together GELL's network of investigators and academic institutions in more than 20 countries with Massive Bio's AI-driven clinical trial matching platform, expanding scientific exchange and patient access to precision oncology.

Read the full announcement: https://www.businesswire.com/news/home/20260727304237/en/Massive-Bio-and-GELL-Announce-Strategic-Partnership-to-Advance-Research-Medical-Education-and-Artificial-Intelligence-Across-Latin-America-and-the-United-States

Grupo de Estudio Latinoamericano de Linfoproliferativos GELL

07/20/2026

Massive Bio has announced a new partnership with FOMAT, the largest Embedded Research Organization in the United States, to expand AI-powered patient prescreening for oncology clinical trials.

The collaboration brings our AI platform into FOMAT's network of 40+ investigator sites across six states, helping identify eligible cancer patients earlier and reducing delays between diagnosis and trial access. It's launching as a pilot, with a broader rollout planned based on results.

"Prescreening has historically been manual, slow, and inconsistent," said Arturo Loaiza-Bonilla, MD, Co-Founder and Chief Medical AI Officer of Massive Bio. "Embedding AI into FOMAT's community-based sites means we can bring speed and precision to that step without disrupting the physician relationships that make FOMAT's model work."

Read more: https://www.businesswire.com/news/home/20260720835336/en/Massive-Bio-Partners-With-FOMAT-to-Expand-Cancer-Patient-Prescreening-for-Clinical-Trial-Access?utm_source=facebook&utm_medium=organic&utm_campaign=fomat-partnership

07/16/2026

Clinical trials are transforming cancer care. ACS ACTS is a free program powered by unique matching technology, in collaboration with Massive Bio, to connect patients with personalized treatment options for any cancer type, while also assisting with housing, transportation, and other health-related needs.

Learn more about ACS ACTS: cancer.org/acts

07/08/2026

After a breast cancer diagnosis, the days that follow can feel overwhelming. You don't have to figure it all out at once.

Swipe through 4 things to know early on:

🔹 Give yourself a few days before making decisions
🔹 Get your full pathology report (tumor type, stage, hormone status)
🔹 A second opinion is normal, most oncologists expect it
🔹 Ask about clinical trials early, not just as a last resort

Clinical trials can be an option from the first conversation, not just when other treatments stop working.

Check your eligibility: https://massivebio.com/breast-cancer-clinical-trials/?utm_source=facebook&utm_medium=organic&utm_campaign=after_diagnosis_breast_cancer

07/07/2026

UV Safety Awareness Month is here, and a little sun knowledge goes a long way.
A few tips that actually matter:

☀️ Reapply sunscreen every 2 hours, not just once in the morning

☀️ Darker skin tones can get melanoma too, don't skip SPF

☀️ Shade between 11am and 3pm cuts your exposure the most

And if you or someone you love is already navigating a skin cancer diagnosis, know that treatment options and clinical trials exist too.

Massive Bio helps match patients to clinical trials: https://massivebio.com/explore-clinical-trials/?utm_source=facebook&utm_medium=organic&utm_campaign=uv_safety_awareness_month

06/21/2026

Today, we celebrate the fathers who taught us, raised us, and shaped who we are. At Massive Bio, our work is about giving families more time together, because every milestone with dad matters. Happy Father's Day to the fathers fighting cancer, and to every father supporting a loved one through this journey.

Address

Dallas, TX
75202

Telephone

+902162259478

Website

http://www.massivebio.com/

Alerts

Be the first to know and let us send you an email when Massive Bio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Massive Bio:

Want your business to be the top-listed Engineering Company in Dallas?